INTRODUCTION
Like other quantitative techniques, quantification of DNA by real-time PCR requires determining the origin of outlying results. While biological outliers are interesting, outliers due to technical malfunction should be eliminated. Although intense attention has been paid to quality control in the steps preceding PCR, entailing mainly the use of reference genes (1, 2) , quality assessment of real-time PCR itself has been left virtually untreated, despite the prevalence of PCR inhibition that might substantially impair the accuracy of quantification (3) (4) (5) (6) .
Quantification by real-time PCR is sensitive to subtle differences in PCR efficiency between samples. Thus, most quantification methods require that the compared samples have similar PCR efficiency (ABI Prism 7700 Sequence Detection System, User Bulletin #2. Applied Biosystems, Foster City, CA, USA) (7, 8) . For samples that have a cycle threshold (C t ) of less than 35, indicating reproducible quantification, as suggested by Soong et al. (9) , a possible quality assessment for real-time PCR should focus on the strict requirement for similar PCR efficiencies among compared reactions of the same gene.
In our earlier work, we described kinetic outlier detection (KOD) as a tool for identifying samples with outlying efficiencies based on their sample-specific efficiency (kinetics). KOD detects outliers by comparing the efficiency of a test sample to the mean efficiency of standard curve samples (10) , where the efficiency sd of standard curve is used as a criterion for high-quality quantification. That is, according to KOD, an outlier is defined as a test sample whose samplespecific efficiency differs from the mean efficiency of the standard curve by more than 2 sd of the efficiency of standard curve.
The KOD method is effective for absolute quantification by real-time PCR, but it was not designed for relative quantification procedures. There are important methodological differences between absolute and relative quantification. While in absolute quantification, a test sample is compared with standard curve samples (2, 11) , in relative quantification, a test sample is compared with other test samples (12, 13) . Therefore, in relative quantification, a test sample should have efficiency similar to the other test samples. As long as all test samples have similar efficiencies, differences in efficiency between test samples and standard curve samples (if used) will affect the significance, but not the trend of the end result, as can be deduced from Pfaffl's work (13) . Therefore, the aim of the study described here was to develop and test statistical tools for verification of efficiency similarity between test samples in relative quantification.
To assess whether test samples indeed have similar efficiencies, we estimated sample-specific efficiencies using a modified version of the method published by Liu and Saint (14) and Tichopad et al. (15) (see the supplementary material available online at www.BioTechniques.com for details). We then applied two methods to assess the comparability and quality of test samples: (i) adjustment of KOD to relative quantification (hereafter called "adjusted KOD"), where the efficiency of a test sample is compared with the mean of the efficiencies of other test samples, and (ii) a "variance test," which is a comparison of test samples' efficiency variance (S 2 E _test ) to the efficiency variance of highly reproducible quantifications (S 2 E _rep ).
MATERIALS AND METHODS

Experimental Design
A natural means of studying the effect of efficiency differences between samples on quantification would be to compare the amounts of a quantified gene. However, in practice, the steps preceding PCR (i.e., nucleic acid extraction, purification, and reverse transcription) also influence the quantification. The common procedure to deal with this problem is to normalize the expression of target genes to that of one or more stably expressed reference genes in the same sample (1, 16) . Therefore, to study the effect of unequal efficiencies on quantification, we applied this internal reference concept. Instead of studying absolute amounts, the effect of dissimilar efficiencies was studied from the ratios of two genes 
SHORT TECHNICAL REPORTS
(Hprt and Ppia), where the efficiency of one gene (Ppia) is similar in all compared samples, and the efficiency of the other gene (Hprt) varies.
Ppia and Hprt expression was quantified in 75 cDNA samples from 5 different brain parts of 15 rats ( Figure  1 ). Hprt expression was quantified in each cDNA sample, first by an inexperienced investigator and then by an expert. Ppia expression was quantified by the expert only. This gave a total of 225 measurements of gene expression level (150 performed by the expert and 75 by the inexperienced investigator). Efficiencies were estimated from every amplification curve using the method described in the supplementary material.
High similarity of efficiencies in all replicate sets of one gene (Ppia) and a range of similarities in the other gene (Hprt) reduced the number of occurrences in which inhibition in one gene in a sample might be compensated by similar inhibition in the other gene in the same sample. This simplified the demonstration of the effect of efficiency dissimilarity on quantification.
One out of the 225 test reactions was excluded because no signal was obtained. Two samples with anomalously low expression of Ppia were excluded from the study despite the fact that they were not identified as outliers by the examination of the estimated efficiency. It could be that these two low quantities resulted from temporal inhibition of Taq DNA polymerase at early cycles, inhibition that probably ended before the detectable phase and therefore could not be identified by kinetics quality assessment tests.
Mathematical Models for Quality Assessment Tests
Both the adjusted KOD and the variance test use the efficiency variance of highly reproducible quantifications: S 2 E _rep . The source of these quantifications can be a standard curve with high correlation between the C t values and Log(DNA amount), typically 0.99 in 10-fold dilution series, or with a mean square error (the mean distance of data points from their regression) of less than 0. The first test we examined was adjusted KOD. The steps describing the test are listed in Protocol 1. A small P value (e.g., 0.05 or lower) indicates low probability that the efficiency of the test sample originated from the same distribution as the mean efficiency of experimentally relevant samples: that is, the tested sample is an outlier. If an internal source of variance was used, Φ should be replaced with the cumulative distribution function for the student t distribution with n -1 degrees of freedom.
The second test we examined was the variance test, which is described in the steps listed in Protocol 2. The χ 2 value calculated from the equation in Protocol 2 is tested against a table value with n -1 degrees of freedom and a significance level α of 0.05 or less. If the calculated χ 2 is larger than the table value, the hypothesis that S 2 E _test ≤ S 2 E _rep is rejected, and the set is considered low quality.
Protocol 1. Adjusted KOD to Relative Quantification
Step 1: Select a source of variance as described below (i.e., internal or external) and calculate S 2 E _rep .
Step 2: Estimate the mean efficiency, Ē of the experimentally relevant samples to which test samples will be compared. In relative quantification, these are the other n test samples, whereas in absolute quantification, these are the n samples of the standard curve.
Step 3: If external source of variance is used, use Equation 1 to evaluate the probability that the efficiency of a test sample, E test , originates from the same distribution as the mean efficiency found in Step 2. Note that, unlike in our previous publication (10), this equation takes into account the number of samples used to estimate Ē.
Where Φ is the cumulative distribution function for the standard normal distribution. KOD: kinetic outlier detection.
Protocol 2. A Variance Test for Relative Quantification
Step 1: Group all the test samples to be compared and estimate their variance (S 2 E _test ).
Step 2: Select a source of variance as described below (i.e. internal or external) and calculate S 2 E _rep . 
RESULTS AND DISCUSSION
The data set used in this study consists of relative quantifications of Hprt and Ppia levels from 75 cDNA samples arranged in sets of 5 replicate animals each (Figure 1) . To reduce the effect of steps preceding the PCR on quantification, the ratio of Hprt/ Ppia quantities was examined, as is often done in normalization of gene expression by a reference gene (17, 18) . Figure 2 shows the spread of Hprt/ Ppia quantities (cv%) versus the spread of efficiencies of Hprt S 2 E _test in each set of 5 replicate animals. High correlation was obtained (R = 0.81, P < 0.0001) between the spread of quantities and spread of efficiencies. The strong correlation between efficiencies spread and quantities spread is the rationale for the variance test, which alerts the user of a too-high efficiency spread that might be associated with the high quantities spread.
In the next step, we implemented the variance test on the sets mentioned above, with external source of variance equal to the mean S 2 E _rep of 21 standard curves of 7 genes. This was possible after low correlation was found between mean efficiencies of the standard curves and their variances (R = 0.17, P = 0.45; Supplementary Figure S4) . Ten lowquality sets, with a significantly higher spread of efficiencies compared with highly reproducible quantifications, were identified (in Figure 2 , these are the sets to the right of the vertical line). The spread of quantities (cv% of Hprt/Ppia) in low-quality sets was significantly higher as compared with the spread of quantities in high-quality sets; cv% = 63% versus 26% when using an external source of variance (Wilcoxon rank-sum, P = 0.0001) or cv% = 55% versus 27% when using an internal source of variance (Wilcoxon rank-sum, P = 0.001; data not shown). Outliers were identified by two different versions of KOD: (i) adjusted KOD for relative quantification (i.e., the efficiency of a test sample was compared with the mean efficiency of the other test samples); and (ii) the original KOD (10), a version for absolute quantification (i.e., the efficiency of a test sample was compared with the efficiency of the standard curve samples). Both versions of KOD were tested with external and internal sources of variance. Table 1 summarizes the results of outlier detection and variance testing. It lists the proportion of outliers identified by adjusted KOD and standard KOD in high-and low-quality sets found by internal and external variance tests. When using adjusted KOD, the proportion of outliers was higher in the low-quality sets compared with the high-quality sets (z test, P = 0.0001). False outlier detection, the proportion of outliers in high-quality sets, was lower in adjusted KOD than in standard KOD (z test, P = 0.001 for internal source of variance and P = 0.02 for external source of variance).
All low-quality sets and most of the outliers were found in the inexperienced worker data. However, the data from both workers showed a similar expression pattern-stable expression of Hprt/Ppia at the different drug doses and brain parts (Kruskal-Wallis test, P = 0.17 for the inexperienced worker and P = 0.47 for the experienced worker).
The stable expression of these two genes is known from other studies, and often these two genes are used as housekeeping genes (1). The similarity in expression pattern and difference between the two workers only in the spread of the quantities in the replicate animals could possibly be explained by the pattern of efficiency spread. Despite the large sample size (n1 = 74, n2 = 73), no significant difference was found between the mean efficiencies of the data generated by the two workers (E -1 = 0.887, E -2 = 0.874, two-tailed Student's t-test, unequal variances, P = 0.06); this is contrary to the significant difference in the spread of efficiencies Figure 1 . Experimental design. Five rats were treated with 0.2 mg (+)-MK 801 hydrogen maleate per kilogram body weight, 5 rats were treated with 0.7 mg of the same compound per kilogram body weight, and 5 control rats were given saline and total RNA was extracted from 5 different parts of the brain (10) . After reverse transcription, Hprt was quantified twice, once by an inexperienced worker and again by an expert investigator, and Ppia was quantified by an expert investigator (for details about RNA extraction, reverse transcription, and PCR primers and conditions, please see the supplementary materials available online). The ratio Hprt/Ppia was calculated twice, once for each Hprt quantification, giving a total of 30 sets of 5 replicates each.
(inexperienced S 2 E _test = 2.19 * 10 -3 , experienced S 2 E_test = 6.68 * 10 -4 , F-test, P < 0.0001).
The exponential nature of PCR makes it vulnerable to differences in efficiencies of compared samples. Therefore, most quantification methods require similar PCR efficiencies among compared samples. Although reference genes may properly compensate for PCR inhibition in a target gene, this might not be the situation in all cases because target and reference PCR systems may have different PCR efficiencies and their expression levels might differ substantially, resulting in a different quantitative effect of the inhibitor.
Here we have presented two statistical tools to assess this requirement in relative quantification. Both tools are based on two heuristics: (i) that S 2 E _rep reflects the technical component of S 2 E _test , including instrumental and labor-related errors, and (ii) that PCR efficiency and DNA quantity are associated via the basic equation of PCR (19) . Then, if test samples have efficiencies that are not outliers according to Equation 1, or S 2 E _test ≤ S 2 E _rep , the samples quantification is expected to be accurate with comparability similar to the comparability of the highly reproducible quantifications used in the tests. A quantitative measure for the comparability of samples quantified by a standard curve, in the form of minimum detectable fold difference in initial copy number with 95% confidence is given in the following equation.
where E is the efficiency of the standard curve and MSE is the mean square error of the standard curve (as in LightCycler Technical Note No. LC 11/2000) . If the PCR replicates were used as highly reproducible quantifications, then MSE is replaced by the replicates sd(C t ).
Adjusted KOD reduces falsepositive outlier detection caused by dissimilarity between the efficiencies of the standard curve and the test samples. Although the dissimilarity in efficiency in this study could be a result of two different sources of starting material (purified PCR product versus cDNA), such differences might also appear when inhibitors of Taq DNA polymerase are present in the cDNA pool used for constructing the standard curve (3-6). Interestingly, different inhibitory effects even between replicates were reported earlier in a stringent study of PCR inhibitors by internal control (20) , emphasizing the need for kinetics quality assessment for each sample. The frequency of PCR inhibition (15) suggests that adjusted KOD would be relevant to a large number of studies.
Adjusted KOD and the variance test may be combined by first detecting and excluding outliers and then testing the variance. In this sequence, the variance test can alert the user of the presence of subsets of efficiencies, as in bipolar or multipolar distribution, which may have different efficiencies even though they are not outliers. Unfortunately, we could not show subsets of efficiencies in the small size sets in this study (n ≤ 5). Based on the S 2 E _rep used in this study, undetectable differences in efficiencies might amount to 0.06-0.09 with profound quantitative consequences. The variance test may be found useful when parameters known to affect PCR efficiency vary between compared samples [e.g., type of tissue (21) or quality of SYBR ® green and dNTPs in and between runs (22,23)].
We conclude that once KOD is adjusted to the method of quantification, it can be used with the variance test for kinetics quality assessment of relative quantification by real-time PCR. However, exclusion of lowquality samples and sets from further analysis should not be automatic because reference genes may properly compensate for the dissimilarity in efficiencies in the target gene. Therefore, until a comprehensive model for kinetics quality assessment for a multiple-gene system is published, we suggest using the variance test and KOD as tools to help the real-time PCR user assign a technical reason to outlying results. That is, samples that are both biological outliers and are of low technical quality should be considered suspect. Once suspect samples are identified, their subsequent processing could include their dilution to reduce inhibitor concentration or repetition of earlier steps in the quantification, possibly with an additional step for the removal of PCR inhibitors. The actual numbers of outliers in each sample are given in parentheses. KOD, kinetic outlier detection.
